G.CLIPS Biotech, a technology platform company, changing the paradigm on targets by enabling the a, generation and validation of conformation-sensitive and pathology-sensitive drug candidates.
We accelerate, advance, and derisk your drug development path since early discovery stages.
#Innovation #Expertise #Biotechnology
expertise
We address major challenges Pharma, biotech, and animal health companies often struggle with:
- Unstable or poorly expressed protein targets that hinder screening and functional assays.
- Unclear mechanisms of action for drug and antibody candidates.
- Inefficient target validation and engagement processes.
- High costs and complexity in developing potency assays.
Key Products or Services
- Protein as targets, in the desired conformation and specific environment for: Screening and selections, functional assays, Immunizations, Structural studies, Yeast and phage display.
- Functional testing and profiling of drugs / antibody candidates on pathology-like targets
- Target Validation and Engagement
- Simple and Cost-Effective Potency Assay
Vous souhaitez en savoir plus?
Rosie Dawaliby
Co-Founder & CEO
rosie.dawaliby@gclips-biotech.com
+33 6 59 96 56 05
Member of
